Revolution Medicines, Inc. (RVMD) Total liabilities 2019–2025
Revolution Medicines, Inc. (RVMD) total liabilities at each fiscal year-end, per SEC filings.
$723.2MFY2025 · since FY2019: $68.0M → $723.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $723.2M | +146.7% |
| FY2024 | $293.1M | +24.5% |
| FY2023 | $235.5M | +85.8% |
| FY2022 | $126.7M | -6.4% |
| FY2021 | $135.4M | +46.0% |
| FY2020 | $92.7M | +36.4% |
| FY2019 | $68.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice